IRIS
BUONERBA, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.041
EU - Europa 597
AS - Asia 207
AF - Africa 38
Totale 1.883
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.024
IT - Italia 252
NL - Olanda 111
CN - Cina 102
VN - Vietnam 56
GB - Regno Unito 46
UA - Ucraina 45
DE - Germania 37
CI - Costa d'Avorio 36
IN - India 36
IE - Irlanda 33
SE - Svezia 31
FI - Finlandia 25
CA - Canada 17
BE - Belgio 5
DK - Danimarca 4
FR - Francia 4
HK - Hong Kong 4
IR - Iran 3
MA - Marocco 2
AT - Austria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
HR - Croazia 1
JP - Giappone 1
KZ - Kazakistan 1
NP - Nepal 1
RS - Serbia 1
SG - Singapore 1
TR - Turchia 1
Totale 1.883
Salva come PNG Salva come JPEG
Città #
Chandler 207
Amsterdam 111
Naples 111
Ashburn 93
Millbury 59
Dong Ket 56
Beijing 39
Lawrence 38
Boston 36
Napoli 34
Des Moines 33
Princeton 27
Nanjing 22
Wilmington 21
Washington 16
Ottawa 15
Fairfield 8
Hebei 8
Nanchang 8
Seattle 8
Dublin 7
Caserta 6
Jacksonville 6
Norwalk 6
Redwood City 6
Shenyang 6
Changsha 5
Los Angeles 5
Milan 5
Woodbridge 5
Courcelles 4
Dearborn 4
Hong Kong 4
Houston 4
Kronberg 4
Tianjin 4
Ann Arbor 3
Ardabil 3
Augusta 3
Aversa 3
Boardman 3
Catania 3
Falls Church 3
New York 3
Pune 3
Rome 3
Dalmine 2
Kochi 2
Kunming 2
Latina 2
Locate di Triulzi 2
Monmouth Junction 2
Piana 2
Pontedera 2
Rovereto 2
Saint-Fons 2
Salerno 2
Shanghai 2
Tronzano Vercellese 2
Agadir 1
Bandar Seri Begawan 1
Brussels 1
Casablanca 1
Cinisello Balsamo 1
Cormeilles-en-Parisis 1
Crispano 1
Darmstadt 1
Edinburgh 1
Florence 1
Frankfurt am Main 1
Ghedi 1
Gunzenhausen 1
Hangzhou 1
Hanover 1
Hefei 1
Indiana 1
Jenera 1
Jiaxing 1
Jinan 1
Kathmandu 1
Leawood 1
Macerata Campania 1
Manassas 1
Marcianise 1
Mondragone 1
Mugnano Di Napoli 1
Mumbai 1
Novi Sad 1
Nürnberg 1
Orange 1
Phoenix 1
Piacenza 1
Redmond 1
San Mateo 1
Sant'Antonio Abate 1
Sciacca 1
Singapore 1
Somma Vesuviana 1
Sorrento 1
Taizhou 1
Totale 1.128
Salva come PNG Salva come JPEG
Nome #
Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up 140
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 51
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 49
A comprehensive outlook on inracerebral therapy of malignant gliomas 46
A third-line sorafenib aftrer sequential therapy with sunitinib and mTOR inhibitors in methastatic renal cell carcinoma 41
Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison. 40
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 40
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme? 39
Castration-resistant prostate cancer: current and emerging treatment strategies 39
Biomarkers in localized prostate cancer 38
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 38
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 38
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 38
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis 37
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 36
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 36
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 35
The tnfrsf13c h159y variant is associated with severe covid-19: A retrospective study of 500 patients from southern italy 35
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 34
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 34
Efficacy of rituximab in gastric diffuse large B cell Lymphoma patients. 33
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 33
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 32
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 32
A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient. 31
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 31
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 30
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 30
Locally advanced paranasal sinus carcinoma: A study of 30 patients 30
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 29
The emerging role of obesity, diet and lipid metabolism in prostate cancer 29
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 29
Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review 29
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 29
The use of chest ultrasonography in suspected cases of COVID-19 in the emergency department 29
Lack of cumulative toxicity associated with cabazitaxel use in prostate cancer 28
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 28
Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy 28
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 27
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 27
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone 25
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 25
Imatinib mesylate in thymic epithelial malignancies. 25
Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study 25
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation 24
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 24
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 24
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 24
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 23
Regulatory noncoding and predicted pathogenic coding variants of ccr5 predispose to severe covid-19 22
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 22
An adjusted indirect comparison of everolimus andsorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples 21
COVID-19 and prostate cancer: A complex scenario with multiple facets 21
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): A population-based study 21
Phase II Study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 20
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 19
Liquid biopsy in bladder cancer: State of the art and future perspectives 19
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities 18
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients 17
Urologic malignancies: advances in the analysis and interpretation of clinical findings 16
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 16
Ten-year adjuvant treatment with somatostatin analogs in a patient with atypical carcinoid of the lung. 15
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting 14
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 12
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 12
Fascin-1 and its role as a serological marker in prostate cancer: A prospective case-control study 10
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 2
Current imaging evaluation of tumor response to advanced medical treatment in metastatic renal-cell carcinoma: Clinical implications 1
Totale 1.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020141 48 3 1 3 1 4 8 9 3 18 36 7
2020/2021192 7 2 10 6 14 22 10 1 14 11 23 72
2021/2022556 20 6 10 2 3 5 8 13 144 45 159 141
2022/2023611 66 25 33 15 73 62 8 63 100 112 46 8
2023/2024379 12 67 85 36 25 55 3 64 24 7 1 0
Totale 1.995